Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Gorman Kevin Charles
Over the trailing 90 days, Gorman Kevin Charles (Director at NEUROCRINE BIOSCIENCES INC) traded $46.8M of stock (net selling $29.0M) across 2 companies, per 7 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 7 transactions · CIK 1201096
- Net activity
- −$29.0M ($8.9M bought · $37.9M sold)
By Company (Trailing 90 Days)
Transactions (7)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-16 | XNCR | Buy | 10.3K | $0 | Grant, award or other acquisition |
| 2026-06-16 | XNCR | Buy | 20.6K | $0 | Grant, award or other acquisition |
| 2026-06-15 | XNCR | Sell | 7.5K | $93K | Open market or private sale |
| 2026-05-27 | NBIX | Buy | 5.2K | $0 | Grant, award or other acquisition |
| 2026-05-19 | NBIX | Sell | 205.1K | $0 | Exercise or conversion of derivative security |
| 2026-05-19 | NBIX | Buy | 205.1K | $8.9M | Exercise or conversion of derivative security |
| 2026-05-19 | NBIX | Sell | 245.1K | $37.8M | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Gorman's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.